Previous studies showed that mutations in the c-KIT or platelet-derived growth factor receptor (PDGFR) drive ligand-independent constitutive kinase activity and downstream signaling, resulting in increased proliferation, migration, and survival of pancreatic cancer cells [11,28,29,30]. This evidence concerns the gene PDGFRB and familial pancreatic carcinoma.